Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer’s disease mice

No abstract is available for this paper.

• Publication year

  2017

• Venue

  JBIC Journal of Biological Inorganic Chemistry

• Publication date

  2017-05-13

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1007/s00775-017-1463-2PMID 28502066
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The PTEN inhibitor bpV(pic) promotes neuroprotection against amyloid β-peptide (25-35)-induced oxidative stress and neurotoxicity

  2017cited by this paper
• Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple‐Transgenic Alzheimer's Disease Mice

  2016cited by this paper
• Diphenyl diselenide attenuates oxidative stress and inflammatory parameters in ulcerative colitis: A comparison with ebselen.

  2016cited by this paper
• Selenomethionine reduces the deposition of beta-amyloid plaques by modulating β-secretase and enhancing selenoenzymatic activity in a mouse model of Alzheimer's disease.

  2016cited by this paper
• The Essential Role of Soluble Aβ Oligomers in Alzheimer’s Disease

  2016cited by this paper
• The Protective Effect of Icariin on Mitochondrial Transport and Distribution in Primary Hippocampal Neurons from 3× Tg-AD Mice

  2016cited by this paper
• Selenomethionine Ameliorates Neuropathology in the Olfactory Bulb of a Triple Transgenic Mouse Model of Alzheimer’s Disease

  2016cited by this paper
• Selenite and ebselen supplementation attenuates d-galactose-induced oxidative stress and increases expression of SELR and SEP15 in rat lens

  2016cited by this paper
• Histidine-tryptophan-ketoglutarate solution with added ebselen augments myocardial protection in neonatal porcine hearts undergoing ischemia/reperfusion.

  2015cited by this paper
• Potential Roles of Selenium and Selenoproteins in the Prevention of Alzheimer's Disease.

  2015cited by this paper
• Different dose-dependent effects of ebselen in sciatic nerve ischemia-reperfusion injury in rats.

  2015cited by this paper
• Deficiency of Neuronal p38α MAPK Attenuates Amyloid Pathology in Alzheimer Disease Mouse and Cell Models through Facilitating Lysosomal Degradation of BACE1*

  2015cited by this paper
• BDNF prevents amyloid-dependent impairment of LTP in the entorhinal cortex by attenuating p38 MAPK phosphorylation.

  2015cited by this paper
• Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer‐induced AMPA glutamate receptor signaling deficits

  2014cited by this paper
• Selenomethionine Ameliorates Cognitive Decline, Reduces Tau Hyperphosphorylation, and Reverses Synaptic Deficit in the Triple Transgenic Mouse Model of Alzheimer's Disease

  2014cited by this paper
• Oxidative Stress and the Pathogenesis of Alzheimer's Disease

  2013cited by this paper
• Pathogenesis of Abeta oligomers in synaptic failure.

  2013cited by this paper
• Selenium Compounds Prevent Amyloid β-Peptide Neurotoxicity in Rat Primary Hippocampal Neurons

  2013cited by this paper
• Correlation of specific amyloid-β oligomers with tau in cerebrospinal fluid from cognitively normal older adults.

  2013cited by this paper
• The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

  2012cited by this paper
• Ebselen inhibits iron-induced tau phosphorylation by attenuating DMT1 up-regulation and cellular iron uptake.

  2012cited by this paper
• Biochemistry and cell biology of tau protein in neurofibrillary degeneration.

  2012cited by this paper
• Brain Oligomeric &bgr;-Amyloid but Not Total Amyloid Plaque Burden Correlates With Neuronal Loss and Astrocyte Inflammatory Response in Amyloid Precursor Protein/Tau Transgenic Mice

  2011cited by this paper
• Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors

  2011cited by this paper
• Selenium and Alzheimer's Disease: A Systematic Review

  2011cited by this paper
• Microglial p38a MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Ab)

  2011cited by this paper
• In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP.

  2010cited by this paper
• Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models

  2010cited by this paper
• Delineating the Role of Glutathione Peroxidase 4 in Protecting Cells Against Lipid Hydroperoxide Damage and in Alzheimer's Disease

  2010cited by this paper
• Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration.

  2010cited by this paper
• Alzheimer's disease and Notch signaling.

  2009influential reference
• Expression of a Truncated Human Tau Protein Induces Aqueous-Phase Free Radicals in a Rat Model of Tauopathy: Implications for Targeted Antioxidative Therapy

  2009cited by this paper
• Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus

  2008cited by this paper
• Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis.

  2008cited by this paper
• Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins

  2008cited by this paper
• Cognitive profiles in dementia

  2008cited by this paper
• Amyloid beta protein modulates glutamate-mediated neurotransmission in the rat basal forebrain: involvement of presynaptic neuronal nicotinic acetylcholine and metabotropic glutamate receptors.

  2007cited by this paper
• Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy

  2006cited by this paper
• A Century of Alzheimer's Disease

  2006cited by this paper
• Glutathione peroxidase 4 protects cortical neurons from oxidative injury and amyloid toxicity

  2006cited by this paper
• Morris water maze: procedures for assessing spatial and related forms of learning and memory

  2006cited by this paper
• Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.

  2006cited by this paper
• Effect of ebselen and organochalcogenides on excitotoxicity induced by glutamate in isolated chick retina.

  2005cited by this paper
• Pathways towards and away from Alzheimer's disease

  2004cited by this paper
• Redox‐Active Metals, Oxidative Stress, and Alzheimer's Disease Pathology

  2004cited by this paper
• Inhibition of inducible nitric oxide synthase and superoxide production reduces matrix metalloproteinase-9 activity and restores coronary vasomotor function in rat cardiac allografts.

  2004cited by this paper
• Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration.

  2004cited by this paper
• P38 MAP kinase is activated at early stages in Alzheimer's disease brain.

  2003cited by this paper
• The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s Disease

  2002cited by this paper
• Acute Ischemic Stroke Treatment: State of the Art and New Options

  2001cited by this paper
• Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease

  2001cited by this paper
• Microglia: activation and their significance in the central nervous system.

  2001cited by this paper
• Activation of p38 Kinase Links Tau Phosphorylation, Oxidative Stress, and Cell Cycle‐Related Events in Alzheimer Disease

  2000cited by this paper
• The importance of selenium to human health.

  2000cited by this paper
• Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

  1999cited by this paper
• Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease

  1999cited by this paper
• Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

  1999cited by this paper
• Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases

  1997cited by this paper
• Neuroprotective efficacy of ebselen, an anti‐oxidant with anti‐inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion

  1997cited by this paper
• Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death

  1995cited by this paper
• Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding.

  1993cited by this paper
• Developments of a water-maze procedure for studying spatial learning in the rat.

  1984cited by this paper

• Ferroptosis and its contribution to cognitive impairment in Alzheimer's disease: mechanisms and therapeutic potential.

  2025cites this paper
• Herpesvirus initiation of dementias and autoimmune diseases

  2025cites this paper
• Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer’s Disease and Other Neurological Disorders: A Comprehensive Review

  2025cites this paper
• Hormetic mechanism of ebselen: A general mechanistic hypothesis

  2025cites this paper
• Potential Mechanisms of Exercise-Mediated Ferroptosis Regulation in Central Nervous System Diseases

  2025cites this paper
• Metal Ion Signaling in Biomedicine

  2025cites this paper
• A review on benzoselenazoles: synthetic methodologies and potential biological applications.

  2025cites this paper
• NanoBiT-based Analysis of Canine SOD1 Protein Dynamics: Understanding the Role of CCS and Ebselen Derivatives as Potential Therapeutics for Canine Degenerative Myelopathy

  2025cites this paper
• NOX2 in Alzheimer's and Parkinson's disease

  2024cites this paper
• Selenium metabolism and selenoproteins function in brain and encephalopathy

  2024influential citation
• The Role of Gut Microbiota in the Neuroprotective Effects of Selenium in Alzheimer’s Disease

  2024cites this paper
• Nrf2-Mediated Signaling as a Therapeutic Target in Alzheimer’s Disease

  2024cites this paper
• Potential role and therapeutic implications of glutathione peroxidase 4 in the treatment of Alzheimer’s disease

  2024cites this paper
• Se-methylselenocysteine ameliorates mitochondrial function by targeting both mitophagy and autophagy in the mouse model of Alzheimer's disease.

  2024cites this paper
• SELENOK-dependent CD36 palmitoylation regulates microglial functions and Aβ phagocytosis

  2024cites this paper
• NADPH-oxidases as potential pharmacological targets for thrombosis and depression comorbidity

  2024cites this paper
• First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer’s Disease

  2024cites this paper
• Selenium and Alzheimer's disease

  2024cites this paper
• Different Effects and Mechanisms of Selenium Compounds in Improving Pathology in Alzheimer’s Disease

  2023cites this paper
• Chemical Knockdown of Phosphorylated p38 Mitogen-Activated Protein Kinase (MAPK) as a Novel Approach for the Treatment of Alzheimer′s Disease

  2023cites this paper
• Ferroptosis mechanism and Alzheimer's disease

  2023cites this paper
• Blood brain barrier-targeted delivery of double selenium nanospheres ameliorates neural ferroptosis in Alzheimer's disease.

  2023cites this paper
• Evaluation of the Neuroprotective Effect of Organic Selenium Compounds: An in Vitro Model of Alzheimer’s Disease

  2023cites this paper
• Ebselen, Iron Uptake Inhibitor, Alleviates Iron Overload-Induced Senescence-Like Neuronal Cells SH-SY5Y via Suppressing the mTORC1 Signaling Pathway

  2023cites this paper
• МЕДИКАМЕНТОЗНОЙ ПРОФИЛАКТИКИ

  2023cites this paper
• Metallomics analysis of metal exposure and cognitive function in older adults: A combined epidemiological and bioinformatics study.

  2023cites this paper
• New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer's disease.

  2023cites this paper
• The Neurobiology and Therapeutic Potential of Multi-Targeting β-secretase, Glycogen Synthase Kinase 3β and Acetylcholinesterase in Alzheimer's Disease.

  2023cites this paper
• Mechanisms of ferroptosis in Alzheimer's disease and therapeutic effects of natural plant products: A review.

  2023cites this paper
• An Adequate Supply of Bis(ethylmaltolato)oxidovanadium(IV) Remarkably Reversed the Pathological Hallmarks of Alzheimer’s Disease in Triple-Transgenic Middle-Aged Mice

  2022cites this paper
• The Potential Use of Ebselen in Treatment-Resistant Depression

  2022cites this paper
• Current understanding of the interactions between metal ions and Apolipoprotein E in Alzheimer's disease.

  2022cites this paper
• Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathology

  2022cites this paper
• Incorporating Selenium into Heterocycles and Natural Products─From Chemical Properties to Pharmacological Activities.

  2022cites this paper
• Selenium-derivative compounds: a review of new perspectives in the treatment of Alzheimer's disease.

  2022cites this paper
• Ferroptosis in Neurological Disease

  2022cites this paper
• Neuropharmacology of Organoselenium Compounds in Mental Disorders and Degenerative Diseases.

  2022cites this paper
• Esculentoside A alleviates cognitive deficits and amyloid pathology through peroxisome proliferator-activated receptor γ-dependent mechanism in an Alzheimer's disease model.

  2022cites this paper
• Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease

  2022cites this paper
• Ebselen Interferes with Alzheimer’s Disease by Regulating Mitochondrial Function

  2022cites this paper
• Selenomethionine Improves Mitochondrial Function by Upregulating Mitochondrial Selenoprotein in a Model of Alzheimer’s Disease

  2021cites this paper
• Unsaturated mannuronate oligosaccharide ameliorates β-amyloid pathology through autophagy in Alzheimer's disease cell models.

  2021cites this paper
• Roles of Selenoproteins in Brain Function and the Potential Mechanism of Selenium in Alzheimer’s Disease

  2021cites this paper
• Se-Methylselenocysteine (SMC) Improves Cognitive Deficits by Attenuating Synaptic and Metabolic Abnormalities in Alzheimer's Mice Model: A Proteomic Study.

  2021cites this paper
• Toxicology and pharmacology of synthetic organoselenium compounds: an update

  2021cites this paper
• Iron metabolism: pathophysiology and pharmacology.

  2021cites this paper
• Small molecule selenium-containing compounds: Recent development and therapeutic applications.

  2021cites this paper
• Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation

  2021cites this paper
• AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discovery

  2021cites this paper
• Tetrahydroxy stilbene glycoside ameliorates Alzheimer's disease in APP/PS1 mice via glutathione peroxidase related ferroptosis.

  2021cites this paper
• Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer’s Disease

  2021cites this paper
• Ebselen, a multi-target compound: its effects on biological processes and diseases

  2021cites this paper
• Novel pharmacological strategies to treat cognitive dysfunction in chronic obstructive pulmonary disease.

  2021cites this paper
• Iron Homeostasis Disorder and Alzheimer’s Disease

  2021cites this paper
• Ebselen prevents cigarette smoke-induced cognitive dysfunction in mice by preserving hippocampal synaptophysin expression

  2021cites this paper
• Glutathione peroxidase-1 and neuromodulation: novel potentials of an old enzyme.

  2020cites this paper
• Advances in amyloid beta oligomer detection applications in Alzheimer's disease

  2020cites this paper
• Preventive and Therapeutic Strategies in Alzheimer's Disease: Focus on Oxidative Stress, Redox Metals, and Ferroptosis

  2020cites this paper
• Selenium Restores Synaptic Deficits by Modulating NMDA Receptors and Selenoprotein K in an Alzheimer's Disease Model

  2020cites this paper
• Bis(ethylmaltolato)oxidovanadium (IV) mitigates neuronal apoptosis resulted from amyloid-beta induced endoplasmic reticulum stress through activating peroxisome proliferator-activated receptor γ.

  2020cites this paper
• The Protective Effect of Vanadium on Cognitive Impairment and the Neuropathology of Alzheimer’s Disease in APPSwe/PS1dE9 Mice

  2020cites this paper
• Ebselen reversed peripheral oxidative stress induced by a mouse model of sporadic Alzheimer's disease

  2020cites this paper
• Characterization and Neuroprotection Potential of Seleno-Polymannuronate

  2020cites this paper
• Soluble Epoxide Hydrolase and Brain Cholesterol Metabolism

  2020cites this paper
• An adenoviral vector encoded with the GPx-1 gene attenuates memory impairments induced by β-amyloid (1-42) in GPx-1 KO mice via activation of M1 mAChR-mediated signalling

  2020cites this paper
• His-Rich Domain of Selenoprotein P Ameliorates Neuropathology and Cognitive Deficits by Regulating TrkB Pathway and Zinc Homeostasis in an Alzheimer Model of Mice.

  2020cites this paper
• Mechanisms of ebselen as a therapeutic and its pharmacology applications.

  2020cites this paper
• The essential elements of Alzheimer’s disease

  2020cites this paper
• Glutathione Peroxidase-1 Knockout Facilitates Memory Impairment Induced by β-Amyloid (1–42) in Mice via Inhibition of PKC βII-Mediated ERK Signaling; Application with Glutathione Peroxidase-1 Gene-Encoded Adenovirus Vector

  2020cites this paper
• Chronic Sodium Selenate Treatment Restores Deficits in Cognition and Synaptic Plasticity in a Murine Model of Tauopathy

  2020cites this paper
• Transcription Factor NRF2 as a Promising Therapeutic Target for Alzheimer's Disease.

  2020cites this paper
• A multifunctional compound ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer's disease.

  2019cites this paper
• Reductive Reprogramming: A Not-So-Radical Hypothesis of Neurodegeneration Linking Redox Perturbations to Neuroinflammation and Excitotoxicity

  2019cites this paper
• A disease-modifying treatment for Alzheimer’s disease: focus on the trans-sulfuration pathway

  2019cites this paper
• Development and Therapeutic Potential of Selenazo Compounds.

  2019cites this paper
• The role of NOX inhibitors in neurodegenerative diseases

  2019cites this paper
• Elucidation of the Molecular Characteristics of Wild-Type and ALS-Linked Mutant SOD1 Using the NanoLuc Complementation Reporter System

  2019cites this paper
• Recent advances in the treatment of C. difficile using biotherapeutic agents

  2019cites this paper
• Diet and Nutrition, and their Influence on Alzheimer's Disease and other Neurodegenerative Diseases

  2019cites this paper
• Ebselen inhibits the activity of acetylcholinesterase globular isoform G4 in vitro and attenuates scopolamine‐induced amnesia in mice

  2018cites this paper
• Yacon leaf extract supplementation demonstrates neuroprotective effect against memory deficit related to β-amyloid-induced neurotoxicity

  2018cites this paper
• The Role of Tau Protein in Diseases

  2018cites this paper
• Comparison of the effects of selenomethionine and selenium-enriched yeast in the triple-transgenic mouse model of Alzheimer's disease.

  2018cites this paper
• The interaction of selenoprotein F (SELENOF) with retinol dehydrogenase 11 (RDH11) implied a role of SELENOF in vitamin A metabolism

  2018cites this paper
• Se‐Methylselenocysteine Ameliorates Neuropathology and Cognitive Deficits by Attenuating Oxidative Stress and Metal Dyshomeostasis in Alzheimer Model Mice

  2018cites this paper
• Recent Advances in the Inhibition of p38 MAPK as a Potential Strategy for the Treatment of Alzheimer’s Disease

  2017cites this paper